About Us

LIPID MAPS Lipidomics Gateway was created in 2003 via an NIH “Glue Grant” to provide access to lipid nomenclature, databases, tools, protocols, standards, tutorials, meetings, publications, and other resources and serving the international lipid research community. In July 2016, the Wellcome Trust approved a proposal to further maintain and develop LIPID MAPS. The bid, led by Valerie O’Donnell (Cardiff) with Michael Wakelam (Babraham, Cambridge), Shankar Subramaniam and Ed Dennis (UCSD) provides £1.3M for 5 yrs.

This new phase will see that LIPID MAPS is maintained and importantly, further developed in line with the global demand and development of lipidomics. It has recently moved to the UK, preserving its internationally recognized classification system and curated lipid structure database, the largest in the world.

LIPID MAPS will support the integrative systems-level analyses of multiomics measurements in human physiology and pathophysiology.

The Strategic Management Committee will consider and oversee all matters related to the routine management and maintenance of the LIPID MAPS website, database and resource. It will adhere to the Wellcome Trust guidelines for management and development of the LIPID MAPS Lipidomics Gateway.

Strategic Management Group Membership

  • Valerie O’Donnell (Chair), Cardiff University, UK
  • Michael Wakelam, Babraham Institute, UK
  • Edward Dennis, University of California San Diego, USA
  • Shankar Subramaniam, University of California San Diego, USA

The Nomenclature Group will continue to monitor and expand the LIPID MAPS lipid classification, nomenclature, and structural drawing guidelines as appropriate and respond to user input and questions. When warranted it should coordinate publication of updated guidelines.

Nomenclature Group Membership

  • Edward Dennis (Chair), University of California San Diego, USA
  • Fritz Spener, University and Medical University of Graz, Austria
  • Junken Aoki, Tohoku University, Japan
  • Robert Murphy, University of Colorado School of Medicine Denver, USA
  • Al Merrill, Georgia Institute of Technology, USA
  • Bill Griffiths, Swansea University, UK
  • Eoin Fahy, University of California San Diego, USA
  • Shankar Subramaniam, University of California San Diego, USA
  • Michael Wakelam, Babraham Institute, UK

Nomenclature Subgroup Membership

  • Fritz Spener (Chair), University and Medical University of Graz, Austria
  • Bill Griffiths, Swansea University, UK
  • Gerhard Liebisch, University of Regensburg, Germany
  • Robert Murphy, University of Colorado School of Medicine Denver, USA
  • Valerie O’Donnell, Cardiff University, UK

This group will consider all matters relating to the scientific direction of the LIPID MAPS Lipidomics Gateway, managed at Cardiff University and operated jointly at Cardiff, Babraham Institute and the University of California San Diego.

Lipidomics Tools and Technical Group Membership

  • Shankar Subramaniam (Chair), University of California San Diego, USA
  • Michael Wakelam, Babraham Institute, UK
  • Valerie O’Donnell, Cardiff University, UK
  • Eoin Fahy, University of California San Diego, USA
  • Dawn Cotter, University of California San Diego, USA
  • An Nguyen, Babraham Institute, UK
  • Simon Andrews, Babraham Institute, UK
  • Robert Andrews, Cardiff University, UK
  • Kim Ekroos, Lipidomics Consulting Ltd, Finland
  • Gerhard Liebisch, University of Regensburg, Germany
  • Maria Valdivia, Cardiff University, UK
  • Egon Willighagen, Maastricht University, Netherlands

This group will work together to identify business development and scientific/academic partnerships. The group will seek to identify engagement opportunities and develop revenue to secure the sustainability of the LIPID MAPS Lipidomics Gateway.

Partnership Group Membership

  • Michael Wakelam (Chair), Babraham Institute, UK
  • Caroline Jeffs, Cardiff University, UK
  • Shankar Subramaniam, University of California San Diego, USA
  • Valerie O’Donnell, Cardiff University, UK
  • Edward Dennis, University of California San Diego, USA
  • Makoto Arita, RIKEN Center for Integrative Medical Sciences, Yokohama City, Japan
  • Markus Wenk, National University of Singapore, Singapore
  • Kirk Makey, Founder and CEO, Cayman Chemical Company, Ann Arbor, Michigan, USA
  • Walt Shaw, Founder and CEO, Avanti Polar Lipids, Alabaster, Alabama, USA

The Advisory Board initially incorporated all existing members of the International Lipid Classification and Nomenclature Committee (ILCNC), along with new members based on academic background and geographical location. The Advisory Board was replaced the Strategic Management Group, Nomenclature Group, and Lipidomics Tools and Technical Group in September, 2018.

(Former) Advisory Board Membership

  • Edward Dennis (Advisory Board Chair), University of California San Diego, USA
  • Valerie O’Donnell, Cardiff University, UK
  • Shankar Subramaniam, University of California San Diego, USA
  • Michael Wakelam, Babraham Institute, UK
  • Al Merrill, Georgia Institute of Technology, USA
  • Fritz Spener, University and Medical University of Graz, Austria
  • Robert Murphy, University of Colorado School of Medicine Denver, USA
  • Takao Shimizu, University of Tokyo, Japan
  • Markus Wenk, National University of Singapore, Singapore
  • Bill Griffiths, Swansea University, UK
  • Eoin Fahy, University of California San Diego, USA